Dr. Reddys Labs (RDY) Misses Q2 EPS by 1c

Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $997 million versus the consensus estimate of $1.02 billion.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• Anthropic Expected to Tell Investors It Sees a More Than $30T Total Addressable Market - WSJ
• Photronics, Inc. (PLAB) call put ratio 5 calls to 1 put into quarter results
• Urban Outfitters (URBN) call put ratio 1 call to 1.2 puts into quarter results